$3.25 0.08 (+2.52%)
11/6/2009 4:00 PM

Dyax Corp. (DYAX)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications.

Current Price $3.25 Mkt Cap $253.66M
Open $3.12 P/E Ratio 0.00
Prev. Close $3.17 Div. (Yield) N/A (N/A)
Daily Range $3.11 - $3.25 Volume 182,707
52-Wk Range $1.55 - $4.39 Avg. Daily Vol. 363,000

DYAX News and Commentary

Caps

How do you think DYAX will perform vs the S&P 500?

Add Stock to Watchlist

All Members

183 Outperform
22 Underperform
 

All-Star Members

54 Outperform
5 Underperform
 

Wall Street

8 Outperform
2 Underperform
 

Top DYAX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.36)
Submitted February 04, 2009

Dyax is a prickly pear of a baby biotech. Its succulent interior is irresistible, yet no matter how carefully it is approached one always seems to wind up with little spines in one's fingertips. I've been fortunate not to take any permanent injury in… More

majakblue (< 20)
Submitted April 14, 2007

Yeah, yeah, yeah, lets see if any of their candidates get past large scale phase III trials. Lets see if the patients have kidneys and liver left afterwards.

DYAX VS S&P 500 (SPY)

Fools bullish on DYAX are also bullish on:

Recent Community Commentary

Read the most recent pitches from members about DYAX.

Recs

0
Member Avatar bg11235 (96.12) Submitted: 11/3/2009 12:37:53 PM : Outperform Start Price: $3.33 DYAX Score: -4.95

Volatility play on a ranging equity.

Recs

0
Member Avatar wofaintagain (< 20) Submitted: 10/15/2009 12:34:34 PM : Underperform Start Price: $3.22 DYAX Score: -2.76

until drug approval

Recs

0
Member Avatar becon800 (99.77) Submitted: 6/11/2009 11:18:20 AM : Outperform Start Price: $2.49 DYAX Score: -22.55

Huge potential here! FDA set a new date for DYAX's lead cantidate to December. I value the stock price at just above $10. This pitch is made a price of $1.99 per share.

becon 800

Leaderboard

Find the members with the highest scoring picks in DYAX.

Score Leader

shoreham

shoreham (77.76) Score: +162.85

When the news is good it is very very good ... but when the news is bad it is horrid.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
alexmattar 70.21 6/4/2009 Outperform 1Y $1.81 +79.56% +14.70% +64.86
kwinam 85.33 6/4/2009 Outperform 5Y $1.84 +76.63% +15.10% +61.53
Chiownknee2 87.95 6/4/2009 Outperform 5Y $1.87 +73.80% +15.16% +58.63
slingermoonshine < 20 6/15/2009 Outperform 3M $1.99 +63.32% +16.84% +46.48
mbc22 98.24 5/4/2009 Outperform NS $1.99 +63.32% +20.60% +42.72
AlwaysOceanside 81.51 6/15/2009 Outperform 5Y $2.09 +55.50% +15.21% +40.30
LehmanBrosRIP 66.80 6/15/2009 Outperform 5Y $2.09 +55.50% +15.21% +40.30
PoFolkStocks 74.41 6/30/2009 Outperform 5Y $2.08 +56.25% +16.10% +40.15
chuckfoss 93.61 4/20/2009 Outperform 3Y $1.95 +66.67% +26.54% +40.12
zulubaby 65.49 6/17/2009 Outperform 5Y $2.06 +57.77% +18.18% +39.59

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackThinkEquity 69.79 9/10/2009 Outperform NS $3.83 -15.14% +3.70% -18.85
TrackNeedham < 20 7/22/2009 Outperform NS $3.61 -9.97% +12.41% -22.38
TrackWedbush < 20 3/27/2009 Outperform NS $2.46 +32.11% +31.92% +0.19
TrackUBS 86.41 7/30/2008 Outperform NS $4.29 -24.24% -13.52% -10.73
TrackSusquehanna 74.76 1/11/2008 Outperform NS $3.57 -8.96% -20.69% +11.73
TrackCreditSuiss 91.16 10/3/2007 Outperform NS $3.60 -9.72% -27.03% +17.31
TrackJimCramer < 20 4/16/2007 Underperform 3W $5.65 -42.48% -22.79% +19.68
TrackMorganJos < 20 3/15/2007 Outperform NS $3.56 -8.71% -18.18% +9.47
TrackInfiniumSec < 20 8/28/2006 Outperform NS $3.40 -4.41% -11.92% +7.51

Featured Broker Partners